04/02/2026
1 in 31 children in the U.S. is now identified with autism spectrum disorder. In 2000, it was 1 in 150.
That shift reflects better screening and reduced stigma — but the systems built to support autistic people haven't kept pace with the scale. Only 20–30% of autistic adults are employed full-time. Most hit what researchers call a "services cliff" at age 21, when school-based support ends and adult services don't fill the gap.
The United Nations' 2026 World Autism Awareness Day theme — Autism and Humanity — Every Life Has Value — is a call to move past awareness and into action on rights, inclusion, and the research that still needs to happen.
That research is moving. Princeton and the Simons Foundation identified four biologically distinct subtypes of autism using data from more than 5,000 children — a finding published in Nature Genetics that could reshape how every child on the spectrum gets diagnosed and supported. The NIH launched a $50 million Autism Data Science Initiative across 13 projects examining genetic, environmental, and behavioral factors. And Jaguar Gene Therapy's JAG201 — targeting a specific genetic form of autism linked to SHANK3 mutations — is now in Phase I human trials with FDA Fast Track designation, the first gene replacement therapy to reach that milestone for autism. The FDA has also recognized leucovorin as a potential treatment pathway for speech-related deficits in a subset of children with ASD.
The science is advancing. The systems need to catch up.
Comment "IMPACT" for our free roadmap to mobilizing your audience around your mission.